Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD
Christyn Edmundson, MD
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN
Alireza Atri, MD, PhD
Christoph U. Correll, MD
Recognizing Early Signs of LGMD2I/R9
John Vissing, MD, DMSci
The Role of Multidisciplinary Care in LGMD2I/R9
Conrad Weihl, MD, PhD
Integrating Perspectives: The Value of Patient and Caregiver Input
New Frontiers in the Treatment of DMD Across the Age Spectrum
Crystal Proud, MD
John Brandsema, MD
Omer Abdul Hamid, MD
Clinical Conundrums in ARIA: Navigating the Baseline MRI for Anti-Aβ Monoclonal Antibodies
James R. Bateman, MD, MPH
B. Joy Snider, MD, PhD
Jerome A. Barakos, MD
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Charles P. Vega, MD
Clinical Conundrums in ARIA: Navigating Case Scenarios in Your Own Practice Setting
Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Clinical Conundrums in ARIA: How to Manage Asymptomatic ARIA
Clinical Conundrums in ARIA: Differentiating and Navigating ARIA vs Stroke When an Emergent MRI is Unavailable
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Clinical Conundrums in ARIA: How to Manage Severe ARIA
Clinical Conundrums in ARIA: How to Interpret and Manage ARIA-H
Patient-Centric Innovations in MS Care: High-Efficacy DMT’s, Cognition, and Special Patient Populations
Ahmed Z. Obeidat, MD, PhD
MS Cognitive Insights: Management, Diagnostic, and Treatment Strategies
Mark S. Freedman, MSc, MD, FANA, FAAN, CSPQ, FRCPC
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.